DALLARIE JAMISON: Open Payments
NPI 1083079453 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 22 payments from 6 companies in 2025. Trend: 2023 $878 · 2024 $1,022 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $242 |
| ABBVIE INC. | 5 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Almatica Pharma LLC | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
Products named: REXULTI, VRAYLAR, CAPLYTA, LOREEV XR, FANAPT, Sunosi, Auvelity.
Industry payments across AL — which companies pay providers there.
